A citation-based method for searching scientific literature

Michael J Callahan, Christopher P Crum, Fabiola Medeiros, David W Kindelberger, Julia A Elvin, Judy E Garber, Colleen M Feltmate, Ross S Berkowitz, Michael G Muto. J Clin Oncol 2007
Times Cited: 332







List of co-cited articles
848 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.
David W Kindelberger, Yonghee Lee, Alexander Miron, Michelle S Hirsch, Colleen Feltmate, Fabiola Medeiros, Michael J Callahan, Elizabeth O Garner, Robert W Gordon, Chandler Birch,[...]. Am J Surg Pathol 2007
704
53

The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.
Fabiola Medeiros, Michael G Muto, Yonghee Lee, Julia A Elvin, Michael J Callahan, Colleen Feltmate, Judy E Garber, Daniel W Cramer, Christopher P Crum. Am J Surg Pathol 2006
554
40

Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer.
J M Piek, P J van Diest, R P Zweemer, J W Jansen, R J Poort-Keesom, F H Menko, J J Gille, A P Jongsma, G Pals, P Kenemans,[...]. J Pathol 2001
469
35

A candidate precursor to serous carcinoma that originates in the distal fallopian tube.
Y Lee, A Miron, R Drapkin, M R Nucci, F Medeiros, A Saleemuddin, J Garber, C Birch, H Mou, R W Gordon,[...]. J Pathol 2007
563
32

Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers.
Amy Finch, Patricia Shaw, Barry Rosen, Joan Murphy, Steven A Narod, Terence J Colgan. Gynecol Oncol 2006
258
29

Are all pelvic (nonuterine) serous carcinomas of tubal origin?
Christopher G Przybycin, Robert J Kurman, Brigitte M Ronnett, Ie-Ming Shih, Russell Vang. Am J Surg Pathol 2010
297
25

Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy.
C Bethan Powell, Eric Kenley, Lee-May Chen, Beth Crawford, Jane McLennan, Charles Zaloudek, Miriam Komaromy, Mary Beattie, John Ziegler. J Clin Oncol 2005
251
23

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
831
22

Pathologic findings in prophylactic oophorectomy specimens in high-risk women.
Katherine Leeper, Rochelle Garcia, Elizabeth Swisher, Barbara Goff, Benjamin Greer, Pamela Paley. Gynecol Oncol 2002
189
21

Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention.
Joseph W Carlson, Alexander Miron, Elke A Jarboe, Mana M Parast, Michelle S Hirsch, Yonghee Lee, Michael G Muto, David Kindelberger, Christopher P Crum. J Clin Oncol 2008
238
20

Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models.
Ruth Perets, Gregory A Wyant, Katherine W Muto, Jonathan G Bijron, Barish B Poole, Kenneth T Chin, Jin Yun H Chen, Anders W Ohman, Corey D Stepule, Soongu Kwak,[...]. Cancer Cell 2013
311
19

Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.
Amy P M Finch, Jan Lubinski, Pål Møller, Christian F Singer, Beth Karlan, Leigha Senter, Barry Rosen, Lovise Maehle, Parviz Ghadirian, Cezary Cybulski,[...]. J Clin Oncol 2014
331
19

Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol.
C Bethan Powell, Lee-may Chen, Jane McLennan, Beth Crawford, Charles Zaloudek, Joseph T Rabban, Dan H Moore, John Ziegler. Int J Gynecol Cancer 2011
103
19


Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer.
Joan L Walker, C Bethan Powell, Lee-May Chen, Jeanne Carter, Victoria L Bae Jump, Lynn P Parker, Mark E Borowsky, Randall K Gibb. Cancer 2015
138
18


Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
18


Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.
Amy Finch, Mario Beiner, Jan Lubinski, Henry T Lynch, Pal Moller, Barry Rosen, Joan Murphy, Parviz Ghadirian, Eitan Friedman, William D Foulkes,[...]. JAMA 2006
388
17

Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.
Noah D Kauff, Susan M Domchek, Tara M Friebel, Mark E Robson, Johanna Lee, Judy E Garber, Claudine Isaacs, D Gareth Evans, Henry Lynch, Rosalind A Eeles,[...]. J Clin Oncol 2008
350
17

Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199.
Mark E Sherman, Marion Piedmonte, Phuong L Mai, Olga B Ioffe, Brigitte M Ronnett, Linda Van Le, Iouri Ivanov, Maria C Bell, Stephanie V Blank, Paul DiSilvestro,[...]. J Clin Oncol 2014
77
22

TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma--evidence supporting the clonal relationship of the two lesions.
Elisabetta Kuhn, Robert J Kurman, Russell Vang, Ann Smith Sehdev, Guangming Han, Robert Soslow, Tian-Li Wang, Ie-Ming Shih. J Pathol 2012
227
17


Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
Ian J Jacobs, Usha Menon, Andy Ryan, Aleksandra Gentry-Maharaj, Matthew Burnell, Jatinderpal K Kalsi, Nazar N Amso, Sophia Apostolidou, Elizabeth Benjamin, Derek Cruickshank,[...]. Lancet 2016
467
17

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
Noah D Kauff, Jaya M Satagopan, Mark E Robson, Lauren Scheuer, Martee Hensley, Clifford A Hudis, Nathan A Ellis, Jeff Boyd, Patrick I Borgen, Richard R Barakat,[...]. N Engl J Med 2002
863
16

Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers.
Patricia A Shaw, Marjan Rouzbahman, Ellen S Pizer, Melania Pintilie, Heather Begley. Mod Pathol 2009
134
16

Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study.
William H Parker, Michael S Broder, Eunice Chang, Diane Feskanich, Cindy Farquhar, Zhimae Liu, Donna Shoupe, Jonathan S Berek, Susan Hankinson, JoAnn E Manson. Obstet Gynecol 2009
402
16

Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention.
Jessica N McAlpine, Gillian E Hanley, Michelle M M Woo, Alicia A Tone, Nirit Rozenberg, Kenneth D Swenerton, C Blake Gilks, Sarah J Finlayson, David G Huntsman, Dianne M Miller. Am J Obstet Gynecol 2014
166
16

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
Timothy R Rebbeck, Henry T Lynch, Susan L Neuhausen, Steven A Narod, Laura Van't Veer, Judy E Garber, Gareth Evans, Claudine Isaacs, Mary B Daly, Ellen Matloff,[...]. N Engl J Med 2002
998
16

The distal fallopian tube: a new model for pelvic serous carcinogenesis.
Christopher P Crum, Ronny Drapkin, Alexander Miron, Tan A Ince, Michael Muto, David W Kindelberger, Yonghee Lee. Curr Opin Obstet Gynecol 2007
324
15


Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.
Saundra S Buys, Edward Partridge, Amanda Black, Christine C Johnson, Lois Lamerato, Claudine Isaacs, Douglas J Reding, Robert T Greenlee, Lance A Yokochi, Bruce Kessel,[...]. JAMA 2011
710
15

Ovarian cancer risk after salpingectomy: a nationwide population-based study.
Henrik Falconer, Li Yin, Henrik Grönberg, Daniel Altman. J Natl Cancer Inst 2015
205
15

Support of the 'fallopian tube hypothesis' in a prospective series of risk-reducing salpingo-oophorectomy specimens.
Welmoed Reitsma, Geertruida H de Bock, Jan C Oosterwijk, Joost Bart, Harry Hollema, Marian J E Mourits. Eur J Cancer 2013
72
19

A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations.
Ann K Folkins, Elke A Jarboe, Aasia Saleemuddin, Yonghee Lee, Michael J Callahan, Ronny Drapkin, Judy E Garber, Michael G Muto, Shelley Tworoger, Christopher P Crum. Gynecol Oncol 2008
177
13

High-grade serous ovarian cancer arises from fallopian tube in a mouse model.
Jaeyeon Kim, Donna M Coffey, Chad J Creighton, Zhifeng Yu, Shannon M Hawkins, Martin M Matzuk. Proc Natl Acad Sci U S A 2012
245
13

Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations.
Catherine A Shu, Malcolm C Pike, Anjali R Jotwani, Tara M Friebel, Robert A Soslow, Douglas A Levine, Katherine L Nathanson, Jason A Konner, Angela G Arnold, Faina Bogomolniy,[...]. JAMA Oncol 2016
111
13

Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutations.
James R Conner, Emily Meserve, Ellen Pizer, Judy Garber, Michael Roh, Nicole Urban, Charles Drescher, Bradley J Quade, Michael Muto, Brooke E Howitt,[...]. Gynecol Oncol 2014
55
21

Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status.
R Manchanda, A Abdelraheim, M Johnson, A N Rosenthal, E Benjamin, C Brunell, M Burnell, L Side, S Gessler, E Saridogan,[...]. BJOG 2011
72
16

Occult and subsequent cancer incidence following risk-reducing surgery in BRCA mutation carriers.
Mae Zakhour, Yael Danovitch, Jenny Lester, B J Rimel, Christine S Walsh, Andrew J Li, Beth Y Karlan, Ilana Cass. Gynecol Oncol 2016
43
27

BRCA-mutation-associated fallopian tube carcinoma: a distinct clinical phenotype?
Ilana Cass, Christine Holschneider, Nandini Datta, Denise Barbuto, Ann E Walts, Beth Y Karlan. Obstet Gynecol 2005
118
12

Genomics of Ovarian Cancer Progression Reveals Diverse Metastatic Trajectories Including Intraepithelial Metastasis to the Fallopian Tube.
Mark A Eckert, Shawn Pan, Kyle M Hernandez, Rachel M Loth, Jorge Andrade, Samuel L Volchenboum, Pieter Faber, Anthony Montag, Ricardo Lastra, Marcus E Peter,[...]. Cancer Discov 2016
95
12

Incidental carcinomas in prophylactic specimens in BRCA1 and BRCA2 germ-line mutation carriers, with emphasis on fallopian tube lesions: report of 6 cases and review of the literature.
Maria L Carcangiu, Bernard Peissel, Barbara Pasini, Gianbattista Spatti, Paolo Radice, Siranoush Manoukian. Am J Surg Pathol 2006
94
11


Prophylactic salpingectomy in premenopausal low-risk women for ovarian cancer: primum non nocere.
Michele Morelli, Roberta Venturella, Rita Mocciaro, Annalisa Di Cello, Erika Rania, Daniela Lico, Pietro D'Alessandro, Fulvio Zullo. Gynecol Oncol 2013
131
11


Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
803
11



Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC).
Stephanie L Wethington, Kay J Park, Robert A Soslow, Noah D Kauff, Carol L Brown, Fanny Dao, Ebunoluwa Otegbeye, Yukio Sonoda, Nadeem R Abu-Rustum, Richard R Barakat,[...]. Int J Gynecol Cancer 2013
65
15


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.